Harnessing Cannabis for Patient Well-being

Realizing the full potential of the plant Cannabis and making it accessible to patients with the goal of improving their quality of life





2024-06-23 00:00

About Cannbit

Tikun Olam was established in 2006 and acquired by Cannbit Pharmaceuticals in 2019. Tikun Olam-Cannbit is Israel’s first and leading supplier of cannabis. A groundbreaker in clinical research, it is renowned worldwide as a pioneer in the field of modern medical cannabis. Since its establishment, Tikun Olam-Cannbit has treated more than 30,000 patients in Israel from childhood through to old age with a variety of illnesses, and has the most experience worldwide in the treatment of patients and in alleviating their suffering through medical cannabis

Innovation Throughout The Value Chain

Clinical Trials

35 clinical and pre-clinical trials and 19 publications in the world’s leading scientific journals

2 Cultivation Farms - at the Dead Sea and in the North

Genetic R&D. Identical cultivation in changing environmental conditions. 
Organic cultivation using biological pesticides, INDOOR.

Processing Facility

2,100 sq.m adapted to EU-GMP standards, Ready for export. Production capacity of 22 tons of cannabis inflorescences and oils annually. ISO8 Standard for clean rooms, production processes, packaging, and logistics center.

Analytical Laboratory

ISO17025 Standard. 14 different analytical tests. Identification and measurement of more than 28 different plant components.


A storage and distribution service system. Pharmacy, regulatory and marketing services.


A green pharmacy in the heart of Tel Aviv.


More than 10 years of experience. A team of certified nurses (male and female). Counseling and support for patients and their families.

Innovation & Strategic Partnerships

Innovation & Strategic Partnerships